Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders for Vinati Organics Limited. However, the company has highlighted strong demand and capacity utilization: - ATBS capacity is fully utilized at 26,000 tonnes with plans to expand to 40,000 tonnes by April 2019 due to strong market demand and exit of competitor Lubrizol. - IBB capacity has been expanded from 16,000 to 25,000 tonnes, catering to growing demand. - The butylphenol plant is expected to start by April 2019 with ramp-up over FY2020 and FY2021. The company expects growth driven by volu

Future growth expectations in sales/revenue/volumes?

Vinati Organics expects overall sales growth at a CAGR of ~25% for the next 3 years. ATBS volumes are projected to grow by 25%-30% annually for the next 2-3 years, driven by capacity expansion from 26,000 to 40,000 tonnes by April 2019. Butylphenols plant to start by April 2019 with 60-65% capacity utilization in FY2020 and full utilization in FY2021, targeting Rs.350-400 Crores in sales. IBB volumes expected to grow around 15% in FY2020 after subdued growth in FY2019 due to customer shutdown. PAP project’s commercialization is uncertain; management excludes it from near-term projections. Cont

Future growth expectations in earnings/operating earnings/profits/EPS?

Vinati Organics expects profits to grow at 25%-30% annually over the next three years. EBITDA margins are anticipated to sustain around 35%, supported by high-margin ATBS volumes and stable product mix. The company projects a 25% volume growth in ATBS for the next two to three years due to increased capacity and market leadership. Butylphenol plant commissioning in April 2019 will ramp up sales to Rs.350-400 Crores, achieving 60%-65% capacity utilization in FY2020 and full utilization by FY2021. IBB volumes are expected to grow approximately 15% annually from FY2020, recovering from pr

Any current/future new fundraising through debt or equity?

Vinati Organics Limited does not plan to raise any debt for current or future projects. All future projects, including the PAP project, are expected to be funded entirely through internal accruals. The company currently has no debt on the books. Management aims to maintain a payout ratio of about 20%, reinvesting most cash flows back into the business to maximize returns. Cash flows for the current year are expected to be around Rs.400 Crores on Rs.1000 Crores revenues, indicating strong internal funding capability.

Any current/future capex/capital investment/strategic investment?

**ATBS Capacity Expansion:** Increasing from 26,000 to 40,000 tonnes; capex of Rs. 75-80 Crores, expected completion by April 2019. **Butylphenol Plant:** Investment of Rs. 240 Crores, expecting sales of Rs. 350-400 Crores; plant to come on stream by April 2019, ramping up to 65% utilization in first year and 100% subsequently. **PAP Project:** Pilot plant with Rs. 20 Crores investment; commercial decision pending successful pilot trials over next 3-6 months; potential major future project with estimated Rs. 600 Crores capex, 1:1 asset turnover, and 20% EBITDA margins. **Overall Capex Guida

Vinati Organics LtdQ1 FY19Chemicals & Petrochemicals

Vinati Organics Ltd Q1 FY19 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,038.6P/E: 21.6Market Cap: ₹10.8K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2

Vinati Organics expects overall sales growth at a CAGR of ~25% for the next 3 years.
ATBS volumes are projected to grow by 25%-30% annually for the next 2-3 years, driven by capacity expansion from 26,000 to 40,000 tonnes by April 2019.
Butylphenols plant to start by April 2019 with 60-65% capacity utilization in FY2020 and full utilization in FY2021, targeting Rs.350-400 Crores in sales.
IBB volumes expected to grow around 15% in FY2020 after subdued growth in FY2019 due to customer shutdown.
PAP project’s commercialization is uncertain; management excludes it from near-term projections.
Continued focus on new products backed by R&D pipeline to sustain long-term growth.

Margin guidance

Category 3

Vinati Organics expects profits to grow at 25%-30% annually over the next three years.
EBITDA margins are anticipated to sustain around 35%, supported by high-margin ATBS volumes and stable product mix.
The company projects a 25% volume growth in ATBS for the next two to three years due to increased capacity and market leadership.
Butylphenol plant commissioning in April 2019 will ramp up sales to Rs.350-400 Crores, achieving 60%-65% capacity utilization in FY2020 and full utilization by FY2021.
IBB volumes are expected to grow approximately 15% annually from FY2020, recovering from prior customer shutdowns and capacity expansion.
PAP project is uncertain; management advises excluding PAP from near-term projections.
Overall, business growth driven by existing products with new capacities and expansions support a robust earnings growth outlook.

See what Vinati Organics Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Vinati Organics Limited does not plan to raise any debt for current or future projects.
All future projects, including the PAP project, are expected to be funded entirely through internal accruals.
The company currently has no debt on the books.
Management aims to maintain a payout ratio of about 20%, reinvesting most cash flows back into the business to maximize returns.
Cash flows for the current year are expected to be around Rs.400 Crores on Rs.1000 Crores revenues, indicating strong internal funding capability.

Order book

The transcript does not explicitly mention the current or expected order book or pending orders for Vinati Organics Limited.
However, the company has highlighted strong demand and capacity utilization:
- ATBS capacity is fully utilized at 26,000 tonnes with plans to expand to 40,000 tonnes by April 2019 due to strong market demand and exit of competitor Lubrizol.
- IBB capacity has been expanded from 16,000 to 25,000 tonnes, catering to growing demand.
- The butylphenol plant is expected to start by April 2019 with ramp-up over FY2020 and FY2021.
The company expects growth driven by volume growth in ATBS and new customer additions.
Capex plans include Rs. 75-80 Crores for ATBS expansion and Rs. 240 Crores for butylphenol plant.
No specific order book figures or pending order details were provided in the call.

See what Vinati Organics Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

ATBS Capacity Expansion: Increasing from 26,000 to 40,000 tonnes; capex of Rs. 75-80 Crores, expected completion by April 2019.
Butylphenol Plant: Investment of Rs. 240 Crores, expecting sales of Rs. 350-400 Crores; plant to come on stream by April 2019, ramping up to 65% utilization in first year and 100% subsequently.
PAP Project: Pilot plant with Rs. 20 Crores investment; commercial decision pending successful pilot trials over next 3-6 months; potential major future project with estimated Rs. 600 Crores capex, 1:1 asset turnover, and 20% EBITDA margins.
Overall Capex Guidance: Rs. 300 Crores for FY2019 mainly for butylphenols and ATBS expansion; FY2020 capex uncertain, dependent on PAP project.
Funding: All future projects to be funded through internal accruals without additional debt; payout ratio maintained around 20%.

Track Vinati Organics Ltd — get its next earnings analysis in your feed

How does Vinati Organics Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisVinati Organics Ltd

Rev 2Mar 3

See where Vinati Organics Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Vinati Organics Ltd rank in Chemicals & Petrochemicals?

Compare Vinati Organics Ltd against every Chemicals & Petrochemicals company (Q1 FY19) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Vinati Organics Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Alufluoride Ltd (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →